Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

摘要

The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.